Rivaroxaban, Colchicine and Famotidine-Loratadine with specialist supportive clinical care for Long COVID, a multi-site, open-label randomised controlled trial in the UK

VAN DER FELTZ-CORNELIS, CHRISTINA MARIA orcid.org/0000-0001-6925-8956 and Consortium, STIMULATE-ICP (Accepted: 2026) Rivaroxaban, Colchicine and Famotidine-Loratadine with specialist supportive clinical care for Long COVID, a multi-site, open-label randomised controlled trial in the UK. Lancet Infectious Diseases. ISSN: 1474-4457 (In Press)

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

This is an author-produced version of the published paper. Uploaded in accordance with the University’s Research Publications and Open Access policy.
Dates:
  • Accepted: 29 April 2026
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
Date Deposited: 17 Jul 2026 10:00
Last Modified: 17 Jul 2026 10:00
Status: In Press
Refereed: Yes
Open Archives Initiative ID (OAI ID):

Downloads

19_6_2026_Supp appendix_pagenumber


Under temporary embargo

Filename: 19_6_2026_Supp_appendix_pagenumber.pdf

Description: 19_6_2026_Supp appendix_pagenumber

Licence: CC-BY 2.5

Request a copy

file not available

Accepted Version


Under temporary embargo

Filename: Drugs_Manuscript_CLEAN_AB.docx

Description: Drugs_Manuscript_CLEAN_AB

Licence: CC-BY 2.5

Request a copy

file not available

Export

Statistics


CORE (COnnecting REpositories)